Rankings and awards
Novartis is honored to receive numerous awards for progress in research and development, our working environment, and our Corporate Citizenship activities.
A selection is featured here.
-
2011 Scrip Awards
Novartis received three 2011 Scrip Awards: Pharma Company of the Year, Best New Drug and Executive of the Year.
-
Newsweek's 2011 Green Rankings
Novartis ranks no. 34 on the global list of Newsweek’s 2011 “Green Rankings.” For the first time this year, Newsweek expanded its “Green Rankings” to analyze the green score of the 100 biggest companies worldwide.
-
JustMeans' 2011 ranking
Novartis ranks #6 in the “Sustainable Performance Leaders in Pharmaceuticals” list released by JustMeans.
-
Fortune’s 2011 “Top Companies for Leaders”
Novartis ranks #25 in Fortune's 2011 "Global Top Companies for Leaders" and #7 on the "European Top Companies for Leaders" list for the quality of its leadership practices.
-
MedAdNews 2011 “Most Admired Pharmaceutical Company”
Novartis is named “Most Admired Pharmaceutical Company” by MedAdNews.
-
Novartis "SMS for Life" program wins 2011 WSJ Technology Innovation Award in Health-Care IT category.
Novartis Malaria Initiative’s innovative "SMS for Life" program has won the Health-Care IT category of the 2011 Wall Street Journal Technology Innovation Awards. These global awards recognize game-changing innovations that break with conventional ideas or processes, go beyond marginal improvements and have a wide impact in their field. Led by Novartis, in partnership with IBM, Vodafone, the Ministry of Health in Tanzania, and under the umbrella of the Roll Back Malaria Partnership, "SMS for Life" harnesses everyday technology to improve access to essential malaria medicines in rural areas. Since rolling out nationally across Tanzania in April 2011, the program has expanded to Ghana and Kenya.
-
Novartis is the most valuable corporate healthcare brand in Europe and third worldwide.
Novartis was ranked the most valuable healthcare brand in Europe (no. 20) and the third most valuable worldwide (no. 54) in the annual “eurobrand” rankings published by the European Brand Institute, Europe’s leading research institute for intangible assets.
-
MedAdNews 2011 “Top 50 Pharma Companies”
Novartis is named the “Pharmaceutical Company of the Year” by MedAdNews.
-
2011 South-South Award for Global, Health, Technology and Development
The UN-sponsored South-South Award recognizes replicable, scalable projects that successfully address global health issues using information and communications technologies. Professor Klaus Leisinger, president and managing director of the Novartis Foundation for Sustainable Development, received the award for his work in digital health.
-
2011 Dow Jones Sustainability World Index
Novartis is a member of the 2011 Dow Jones Sustainability World Index, which recognizes the leading sustainability-driven companies worldwide.
-
2011 GBC Business Action on Health Awards
'SMS for Life', a Novartis Malaria Initiative program, ranked #1 in Technology for Health category.
-
The Scientist’s Best Places to Work in Industry 2011
Novartis ranked #6 among top 10 large companies.
-
Fortune’s World’s Most Admired Companies 2011
Novartis #1 pharmaceutical company in Fortune's World's Most Admired Companies 2011.
-
SAM Sustainability Yearbook 2011
Novartis awarded Gold Class Medal in SAM's 2011 Sustainability Yearbook.
-
Barron’s World’s Most Respected Companies 2011
Novartis top healthcare company and #24 across industries in Barron's World's Most Respected Companies 2011.
-
National Organization for Rare Disorders Corporate Award
The National Organization for Rare Disorders in the US honors Novartis our research on rare diseases.
-
DiversityInc Top 10 Global Diversity Companies
DiversityInc ranks Novartis No. 7 in its Top 10 Companies for Global Diversity in 2010. In 2009, Novartis was No. 8 on this list.
-
Vaccine Industry Excellence Awards
Novartis Vaccines receives Best Vaccine R&D Pipeline recognition at the 2010 Vaccine Industry Excellence Awards.
-
The Scientist's Best Places To Work for Postdocs
Three locations of the Novartis Institutes for BioMedical Research (NIBR) were recognized in The Scientist's 2010 ranking of the “Best Places to Work for Postdocs” — Horsham, UK, and Basel, Switzerland, as No. 1 and No. 5 in the international list, and Cambridge, Massachusetts, as No. 4 in the US list.
-
Fast Company's World's Most Innovative Companies
Novartis recognized in the “World's Most Innovative Companies” list by Fast Company magazine. Novartis listed as No. 8 on the overall company list, as well as No. 1 on the biotechnology sector list.
